(Total Views: 514)
Posted On: 04/01/2020 7:40:37 PM
Post# of 154102
Hi everyone:
On February 14th I created a post about Leronlimab becoming a vital national security interest and the possibility of it being nationalized. It looks like that scenario may be getting a little closer to reality.
I have a suggestion:
If these Covid trials are successful It is my belief that we should try to sell the entire stock to the government, maybe HHS.
We could sell it for $500 a dose (26,000 annually). We get great press selling it to the government for a reduced price. It would take pressure off of Cytodyn regarding distribution and any claims of gouging.
Assuming that patient needs somewhere between 3-5 weeks that would be $1,500-2500 much cheaper than a ventilator and would save hospitals a huge amount of money.
I would appreciate any feedback
On February 14th I created a post about Leronlimab becoming a vital national security interest and the possibility of it being nationalized. It looks like that scenario may be getting a little closer to reality.
I have a suggestion:
If these Covid trials are successful It is my belief that we should try to sell the entire stock to the government, maybe HHS.
We could sell it for $500 a dose (26,000 annually). We get great press selling it to the government for a reduced price. It would take pressure off of Cytodyn regarding distribution and any claims of gouging.
Assuming that patient needs somewhere between 3-5 weeks that would be $1,500-2500 much cheaper than a ventilator and would save hospitals a huge amount of money.
I would appreciate any feedback
(1)
(0)
